celares GmbH establishes collaboration with NOF
NOF CORPORATION and celares GmbH, Germany have established strategic collaboration in the field of PEGylation. The collaboration will enable NOF CORPORATION to strengthen its position in an increasingly competitive market for Activated PEG supply. Collaboration of celares with NOF means a milestone in company development. In joint client projects, celares will use NOF’s high grade pure Activated PEGs. For celares, the collaboration with NOF means a broadening of its market globally.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Portable device produces biologic drugs on demand

Pushing the boundaries of eco-friendly chemical production - Researchers use light-powered enzymes to modify azaarenes laying the groundwork for a sustainable future
Chest_pain
Max-Planck-Institut für Hirnforschung - Frankfurt am Main, Germany
Protein that increases effectiveness of vaccines detected
Genzyme and Project HOPE Partner to Rebuild Critical Health Care Programs in Tsunami-Affected Areas
